• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Landscape of Cell and Gene Therapies for Solid Tumors.

作者信息

Wang Shuhang, Sun Fa, Huang Huiyao, Chen Kun, Li Qi-Jing, Zhang Lu, Wang Enxiu, Wang Chen, Zhang Hai, Yuan Andy Qingan, Chen Bin, Deng Tao, Liu Yarong, Sun Jingwei, Liu Dongfang, Yu Yue, Fang Yuan, Jiang Ning, Wu Dawei, Fang Hong, Bai Ying, Xing Shujun, Ni Yufen, Fan Qi, Yu Anqi, Sun Chao, Tang Yu, Li Ning, Xu Binghe, He Jie

机构信息

Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Guizhou Provincial People's Hospital, Guiyang, China.

出版信息

Cancer Cell. 2021 Jan 11;39(1):7-8. doi: 10.1016/j.ccell.2020.12.005.

DOI:10.1016/j.ccell.2020.12.005
PMID:33434513
Abstract
摘要

相似文献

1
The Landscape of Cell and Gene Therapies for Solid Tumors.实体瘤的细胞和基因治疗前景
Cancer Cell. 2021 Jan 11;39(1):7-8. doi: 10.1016/j.ccell.2020.12.005.
2
Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.解决伊朗的癌症免疫疗法研究问题：过继细胞疗法即将面世。
Cytotherapy. 2018 Oct;20(10):1227-1237. doi: 10.1016/j.jcyt.2018.08.002. Epub 2018 Sep 26.
3
From CARs to TRUCKs and Beyond: Safely en Route to Adoptive T-cell Therapy for Cancer.从嵌合抗原受体（CAR）到肿瘤浸润淋巴细胞（TIL）及其他：安全踏上癌症过继性T细胞治疗之路
EBioMedicine. 2016 Dec;14:1-2. doi: 10.1016/j.ebiom.2016.11.037.
4
Adoptive Cell Therapy in Treating Pediatric Solid Tumors.过继细胞疗法治疗儿科实体瘤。
Curr Oncol Rep. 2018 Aug 1;20(9):73. doi: 10.1007/s11912-018-0715-9.
5
Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.基于过继性细胞疗法和免疫检查点阻断疗法的实体瘤个性化联合免疫疗法的前景。
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):68-77. doi: 10.2177/jsci.40.68.
6
Future Research Goals in Immunotherapy.免疫疗法的未来研究目标
Surg Oncol Clin N Am. 2019 Jul;28(3):505-518. doi: 10.1016/j.soc.2019.02.006. Epub 2019 Apr 12.
7
Current status and future applications of cellular therapies for cancer.细胞疗法治疗癌症的现状与未来应用。
Immunotherapy. 2011 Apr;3(4):507-16. doi: 10.2217/imt.11.18.
8
Immunomodulation of cancer: potential use of selectively replicating agents.癌症的免疫调节：选择性复制剂的潜在用途。
J Clin Invest. 2000 May;105(9):1173-6. doi: 10.1172/JCI10026.
9
Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy.基于 miRNA 的策略在癌症免疫治疗中的诊断和治疗应用。
Cancer Metastasis Rev. 2018 Mar;37(1):45-53. doi: 10.1007/s10555-017-9716-7.
10
Adoptive T-cell therapy for cancer: The era of engineered T cells.过继性细胞疗法治疗癌症：工程化 T 细胞的时代。
Eur J Immunol. 2015 Sep;45(9):2457-69. doi: 10.1002/eji.201545552. Epub 2015 Aug 21.

引用本文的文献

1
Recent Advances in Anti-Cancer Drugs.抗癌药物的最新进展。
Int J Mol Sci. 2025 Aug 30;26(17):8446. doi: 10.3390/ijms26178446.
2
Current landscape of innovative drug development and regulatory support in China.中国创新药物研发与监管支持的现状
Signal Transduct Target Ther. 2025 Jul 22;10(1):220. doi: 10.1038/s41392-025-02267-y.
3
3D sponge loaded with cisplatin-CS-calcium alginate MPs utilized as a void-filling prosthesis for the efficient postoperative prevention of tumor recurrence and metastasis.负载顺铂-壳聚糖-海藻酸钙微球的3D海绵用作填充性假体，用于术后有效预防肿瘤复发和转移。
RSC Adv. 2024 Mar 4;14(11):7517-7527. doi: 10.1039/d3ra07516h. eCollection 2024 Feb 29.
4
Baicalin-modified polyethylenimine for miR-34a efficient and safe delivery.用于高效安全递送miR-34a的黄芩苷修饰聚乙烯亚胺
Front Bioeng Biotechnol. 2023 Nov 3;11:1290413. doi: 10.3389/fbioe.2023.1290413. eCollection 2023.
5
Approval and therapeutic value of gene therapies in the US and Europe.美国和欧洲基因治疗的审批和治疗价值。
Gene Ther. 2023 Nov;30(10-11):756-760. doi: 10.1038/s41434-023-00402-4. Epub 2023 Nov 8.
6
Evaluation of immunotherapy efficacy in gynecologic cancer.评估妇科癌症的免疫疗法疗效。
Front Immunol. 2023 Jan 31;14:1061761. doi: 10.3389/fimmu.2023.1061761. eCollection 2023.
7
Patient-reported outcomes in adoptive cell-therapy trials: mind the gap.细胞疗法试验中的患者报告结局：关注差距。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-006082.
8
Clinical Investigations of CAR-T Cell Therapy for Solid Tumors.实体瘤嵌合抗原受体 T 细胞治疗的临床研究。
Front Immunol. 2022 Jul 18;13:896685. doi: 10.3389/fimmu.2022.896685. eCollection 2022.
9
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy.间充质干细胞衍生的外泌体作为 miRNA 在癌症治疗中递送的新型载体。
Cancer Gene Ther. 2022 Aug;29(8-9):1105-1116. doi: 10.1038/s41417-022-00427-8. Epub 2022 Jan 26.
10
The state of the art of bispecific antibodies for treating human malignancies.双特异性抗体治疗人类恶性肿瘤的最新进展。
EMBO Mol Med. 2021 Sep 7;13(9):e14291. doi: 10.15252/emmm.202114291. Epub 2021 Aug 24.